Skip to content
Subscriber Only

Sanofi Joins Medtronic to Develop New Diabetes Devices

Sanofi, the maker of the insulin product Lantus, and Medtronic Inc., the world’s biggest maker of heart-rhythm devices, will work together to develop combinations of medicines and devices to battle diabetes, which kills a person every six seconds.

People with the disease must closely track their sugar intake to keep it under control and often need multiple insulin shots a day to survive. The Sanofi-Medtronic pact will also focus on technology-based services that simplify insulin use and improve treatment compliance, the companies said.